Clinical and Pathological Criteria for the Diagnosis of Essential Thrombocythemia, Polycythemia Vera, and Idiopathic Myelofibrosis (Agnogenic Myeloid Metaplasia)-Reference-Cited by-同舟云学术

Clinical and Pathological Criteria for the Diagnosis of Essential Thrombocythemia, Polycythemia Vera, and Idiopathic Myelofibrosis (Agnogenic Myeloid Metaplasia)

Published:2002-08 Issue:2 Volume:76 Page:133-145
ISSN:0925-5710
Container-title:International Journal of Hematology
language:en
Short-container-title:Int J Hematol

Author:

Michiels Jan Jacques,Thiele Juergen

Publisher

Springer Science and Business Media LLC

Subject

Hematology

Link

http://link.springer.com/article/10.1007/BF02982575/fulltext.html

Reference101 articles.

1. Murphy S, Peterson P, Iland H, Laszlo J. Experience of the Poly-cythemia Vera Study Group with essential thrombocythemia: a final report on diagnostic criteria, survival, and leukemic transition by treatment.Semin Hematol. 1997;34:29–39.

2. Murphy S. Diagnostic criteria and prognosis in polycythemia vera and essential thrombocythemia.Semin Hematol. 1999;36:9–13.

3. Kutti J, Wadenvik H. Diagnostic and differential criteria of essential thrombocythemia and reactive thrombocytosis.Leuk Lymphoma. 1996;22(suppl 1):41–45.

4. Jantunen R, Juvonen E, Ikkala E, et al. Essential thrombocythemia at diagnosis: causes of diagnostic evaluation and presence of positive diagnostic findings.Ann Hematol. 1998;77:101–106.

5. Pearson TC. Diagnosis and classification of erythrocytoses and thrombocytoses.Baillieres Clin Haematol. 1998;11:695–720.

Cited by 98 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. How I Diagnose Primary Myelofibrosis;American Journal of Clinical Pathology;2022-03-03

2. Novel European Asiatic Clinical, Laboratory, Molecular and Pathobiological (2015-2020 CLMP) criteria for JAK2V617F trilinear polycythemia vera (PV), JAK2exon12 PV and JAK2V617F, CALR and MPL515 thrombocythemias: From Dameshek to Constantinescu-Vainchenker, Kralovics and Michiels;International Journal of Bone Marrow Research;2020-04-03

3. Bone marrow histology in CALR mutated thrombocythemia and myelofibrosis: results from two cross sectional studies in 70 newly diagnosed JAK2/MPL wild type thrombocythemia patients;International Journal of Bone Marrow Research;2019-06-21

4. The PVSG/WHO versus the Rotterdam European clinical, molecular and pathological diagnostic criteria for the classification of myeloproliferative disorders and myeloproliferative neoplasms (MPD/MPN): From Dameshek to Georgii, Vainchenker and Michiels 1950-2018;International Journal of Bone Marrow Research;2019-04-17

5. Primary myelofibrosis is not primary anymore since the discovery of MPL515 and CALR mutations as driver causes of mono-linear megakaryocytic and dual megakaryocytic granulocytic myeloproliferation and secondary myelofibrosis;International Journal of Bone Marrow Research;2019-04-15